A study of 40 preterm infants (<36 weeks) suggested the use of nebulised salbutamol may be as effective as insulin/dextrose in infants with non-oliguric hyperkalaemia with less impact on blood glucose (108). This evidence concerns the gene INS and Hyperkalemia.